Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Patel

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Environmental Pollution (Barking, Essex : 1987)|October 22, 2022
Characterization and regulation of microplastic pollution for protecting planetary and human healthYoun Soo Jung, Vanitha Sampath, Mary Prunicki, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 4, 2005
Quantitative analysis of orphan G protein-coupled receptor mRNAs by TaqMan Real-Time PCR: G2A and GPR4 lysophospholipid receptor expression in leukocytes and in a rat myocardial infarction-heart failure modelStephen A Douglas, Zhaohui Ao, Douglas G Johns, et al.
Biochemical and Biophysical Research Communications|January 12, 2002
PPARgamma is not a critical mediator of primary monocyte differentiation or foam cell formationLisa Patel, Steven J Charlton, Ian C Marshall, et al.
Health Affairs (Project Hope)|January 22, 2025
Critical Steps To Address Climate, Health, And EquityWilliam H Frist, Sonia Y Angell, Kristie L Ebi, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2025
Phenotypic pharmacology of novel Complex I inhibitors eliciting tissue repair concurrent to control of inflammationLisa Patel, Fatima Garcia-Raposo, Benjamin Moore, et al.
Lancet (London, England)|August 8, 2006
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trialJoseph Eron, Patrick Yeni, Joseph Gathe, et al.
Biochemistry|May 23, 2002
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662Lisa M Leesnitzer, Derek J Parks, Randy K Bledsoe, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Environmental Pollution (Barking, Essex : 1987)|October 22, 2022
Characterization and regulation of microplastic pollution for protecting planetary and human healthYoun Soo Jung, Vanitha Sampath, Mary Prunicki, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 4, 2005
Quantitative analysis of orphan G protein-coupled receptor mRNAs by TaqMan Real-Time PCR: G2A and GPR4 lysophospholipid receptor expression in leukocytes and in a rat myocardial infarction-heart failure modelStephen A Douglas, Zhaohui Ao, Douglas G Johns, et al.
Biochemical and Biophysical Research Communications|January 12, 2002
PPARgamma is not a critical mediator of primary monocyte differentiation or foam cell formationLisa Patel, Steven J Charlton, Ian C Marshall, et al.
Health Affairs (Project Hope)|January 22, 2025
Critical Steps To Address Climate, Health, And EquityWilliam H Frist, Sonia Y Angell, Kristie L Ebi, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2025
Phenotypic pharmacology of novel Complex I inhibitors eliciting tissue repair concurrent to control of inflammationLisa Patel, Fatima Garcia-Raposo, Benjamin Moore, et al.
Lancet (London, England)|August 8, 2006
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trialJoseph Eron, Patrick Yeni, Joseph Gathe, et al.
Biochemistry|May 23, 2002
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662Lisa M Leesnitzer, Derek J Parks, Randy K Bledsoe, et al.
Pageof 4